GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases()

GlycA is a biomarker of systemic inflammation, quantifying both the protein concentrations and glycosylation states of several acute phase proteins. GlycA has been shown to be associated with both subclinical atherosclerosis and with cardiovascular disease (CVD). GlycA levels are higher in acute and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Nehal N., Dey, Amit K., Maddineni, Reethika, Kraus, William E., Huffman, Kim M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315361/
https://www.ncbi.nlm.nih.gov/pubmed/34327480
http://dx.doi.org/10.1016/j.ajpc.2020.100120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315361/
https://www.ncbi.nlm.nih.gov/pubmed/34327480
http://dx.doi.org/10.1016/j.ajpc.2020.100120

Ejemplares similares